Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward

Psychopharmacology

Volumn 149, Issue 3, 2000, Pages 225-234

  Tzschentke, Thomas M ^a   Schmidt, Werner J ^b  

^a GRÜNENTHAL GMBH   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cocaine; Curve shift paradigm; Intracranial self stimulation (ICSS); Lateral hypothalamus; Median forebrain bundle; Memantine; MK 801; Morphine; Reward

Indexed keywords

COCAINE; DIZOCILPINE; MEMANTINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG POTENTIATION; ELECTROSTIMULATION; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; SELF STIMULATION;

ANALGESICS, OPIOID; ANIMALS; COCAINE; DIZOCILPINE MALEATE; DOPAMINE UPTAKE INHIBITORS; DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; HYPOTHALAMIC AREA, LATERAL; MALE; MEMANTINE; MORPHINE; RATS; RATS, LONG-EVANS; REWARD;

EID: 0034098982     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000379     Document Type: Article

References (70)

1. Bailey EV, Stone TW (1975) The mechanism of amantadine in parkinsonism: a review. Arch Int Pharmacodyn 216:246-262
2. Balster RL (1987) The behavioral pharmacology of phencyclidine. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1573-1579
3. Bauco P, Wise RA (1994) Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment. J Pharmacol Exp Ther 271:294-301
4. Bauco P, Wise RA (1997) Synergistic effects of cocaine with lateral hypothalamic brain stimulation reward: lack of tolerance or sensitization. J Pharmacol Exp Ther 283:1160-1167
5. Bauco P, Wang Y, Wise RA (1993) Lack of sensitization or tolerance to the facilitating effect of ventral tegmental area morphine on lateral hypothalamic brain stimulation reward. Brain Res 617:303-308
6. Bauco P, Rivest R, Wise RA (1994) Extracellular nucleus accumbens dopamine and metabolite levels during earned and unearned lateral hypothalamic brain stimulation. Soc Neurosci Abstr 20:823
7. Beardsley PM, Hayes BA, Balster RL (1990) The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. J Pharmacol Exp Ther 252:953-959
8. Beaton JA, Stemsrud K, Monaghan DT (1992) Identification of a novel N-methyl-D-aspartate receptor population in the rat medial thalamus. J Neurochem 59:754-757
9. Bielajew C, Shizgal P (1986) Evidence implicating descending fibers in self-stimulation of the medial forebrain bundle. J Neurosci 6:919-929
10. Blanpied TA, Boeckman FA, Aizenman E, Johnson JW (1997) Trapping channel block of NMDA-activated responses by amantadine and memantine. J Neurophysiol 77:309-323
11. Bormann J (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 166:591-592
12. Bradberry CW, Roth RH (1989) Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci Lett 103:97-102
13. Brenner M, Haaß A, Jacobi P, Schimrigk K (1989) Amantadine sulphate in treating Parkinson's disease: clinical effects, psychometric tests and serum concentrations. J Neurol 236:153-156
14. Bresink I, Danysz W, Parsons CG, Mutschler E (1995) Different binding affinities of NMDA receptor channel blockers in various brain regions - indication of NMDA receptor heterogeneity. Neuropharmacology 34:533-540
15. Carlezon WA Jr, Wise RA (1992) Dizocilpine (MK-801) potentiates low-dose facilitation of brain stimulation reward by both amphetamine and morphine. Soc Neurosci Abstr 18:1575
16. Carlezon WA Jr, Wise RA (1993a) Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res 620:339-342
17. Carlezon WA Jr, Wise RA (1993b) Phencyclidine-induced potentiation of brain stimulation reward: acute effects are not altered by repeated administration. Psychopharmacology 111:402-408
18. Carlezon WA Jr, Wise RA (1996a) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16:3112-3122
19. Carlezon WA Jr, Wise RA (1996b) Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate lateral hypothalamic brain stimulation reward. Psychopharmacology 128:413-420
20. Corbett D (1989) Possible abuse potential of the NMDA antagonist MK-801. Behav Brain Res 34:239-246
21. Corbett D (1991) Cocaine enhances the reward value of medial prefrontal cortex self-stimulation. Neuroreport 2: 805-808
22. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G (1997) Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci Biobehav Rev 21:455-468
23. Ditzler K (1991) Efficacy and tolerability of memantine in patients with dementia syndrome. Arzneimittelforschung 41:773-780
24. Ebert B, Wong EHF, Krogsgaard-Larsen P (1991) Identification of a novel NMDA receptor in rat cerebellum. Eur J Pharmacol 208:49-52
25. Foster AC, Wong EHF (1987) The novel anticonvulsant (+)-MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br J Pharmacol 91:403-409
26. Frankiewicz T, Potier B, Bashir ZI, Collingridge GL, Parsons CG (1996) Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices. Br J Pharmacol 117:689-697
27. French ED, Ceci A (1990) Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci Lett 119:159-162
28. Gallistel CR (1987) Determining the quantitative characteristics of a reward pathway. In: Church RM, Commins ML, Stellar JR, Wagner AR (eds) Biological determinants of reinforcement. Erlbaum, Hillside, N.J., pp 1-30
29. Garris PA, Kilpatrick M, Bunin MA, Michael D, Walker QD, Wightman RM (1999) Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. Nature 398:67-69
30. Gratton A, Hoffer BJ, Gerhardt GA (1988) Effects of electrical stimulation of brain reward sites on release of dopamine in rat: an in vivo electrochemical study. Brain Res Bull 21:319-324
31. Görtelmeyer R, Erbler H (1992) Memantine in the treatment of mild to moderate dementia syndrome: a double-blind placebo-controlled study. Arzneimittelforschung 42:904-913
32. Grossmann W, Schutz W (1982) Memantine and neurogenic bladder dysfunction in spastic conditions. Arzneimittelforschung 32:1273-1276
33. Herberg LJ, Rose IC (1989) The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Psychopharmacology 99:87-90
34. Hoffman DC (1994) The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats. Pharmacol Biochem Behav 47:907-912
35. Hölter SM, Danysz W, Spanagel R (1996) Evidence for alcohol anti-craving properties of memantine. Eur J Pharmacol 314:R1-R2
36. Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31-108
37. Huettner JE, Bean BP (1988) Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci USA 85:1307-1311
38. Kemp JA, Foster AC, Wong EHF (1987) Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci 10:294-299
39. 3H]dibenzocycloalkenimine (MK-801) to the N-methyl-D-aspartate (NMDA) receptor and its therapeutic implication. FEBS Lett 230:167-170
40. Kornhuber J, Weller M (1997) Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biol Psychiatry 41:135-144
41. 3H]-MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166:589-590
42. Kornhuber J, Weller M, Riederer P (1993) Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis. J Neural Transm [PD Sect] 6:63-72
43. Kornhuber J, Quack G, Danysz W, Jellinger K, Danielczyk W, Gsell W, Riederer P (1995) Therapeutic brain concentration of the NMDA receptor antagonist amantadine. Neuropharmacology 34:713-721
44. Layer RT, Kaddis FG, Wallace LJ (1993) The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol Biochem Behav 44:245-247
45. Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11:81-86
46. Matthews RT, German DC (1984) Electrophysiological evidence for excitation of rat ventral tegmental area dopaminergic neurons by morphine. Neuroscience 11:617-626
47. Miliaressis E, Rompre PP, Laviolette P, Phillipe L, Coulombe D (1986) The curve-shift paradigm in self-stimulation. Physiol Behav 37:85-91
48. Nakahara D, Ozaki N, Kapoor V, Nagatsu T (1989) The effect of uptake inhibition on dopamine release from the nucleus accumbens of rats during self or forced stimulation of the medial forebrain bundle: a microdialysis study. Neurosci Lett 104:136-140
49. Nakahara D, Fuchikami K, Ozaki N, Iwasaki T, Nagatsu T (1992) Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis. Brain Res 574:164-170
50. Nicholson KL, Jones HE, Balster RL (1998) Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine. Behav Pharmacol 9:231-243
51. Papp M, Moryl E (1994) Rewarding properties of non-competitive and competitive NMDA antagonists as measured by place preference conditioning in rats. Pol J Pharmacol 46:79-81
52. Parsons CG, Panchenko VA, Pinchenko VO, Tsyndrenko AY, Krishtal OA (1996) Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine. Eur J Neurosci 8:446-454
53. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates (2nd edn). Academic Press, Sydney
54. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates (compact 3rd edn). Academic Press, San Diego
55. Porter RHP, Greenamyre JT (1995) Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. J Neurochem 64:614-623
56. Quack G, Hesselink M, Danysz W, Spanagel R (1995) Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover. J Neural Transm [Suppl] 46:97-105
57. Ranaldi R, Bauco P, Wise RA (1997) Synergistic effects of cocaine and dizocilpine (MK-801) on brain stimulation reward. Brain Res 760:231-237
58. Shizgal P, Murray B (1989) Neuronal basis of intracranial self-stimulation. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Clarendon Press, Oxford, pp 106-163
59. Steinpreis RE, Kramer MA, Mix KS, Piwowarczyk MC (1995) The effects of MK801 on place conditioning. Neurosci Res 22:427-430
60. Toggas SM, Marsliah E, Mucke L (1996) Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 706:303-307
61. Trujillo KA, Akil, H (1991) The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality. Pharmacol Biochem Behav 38:673-675
62. Tzschentke TM, Schmidt WJ (1995) N-methyl-D-aspartic acid receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 193:37-40
63. Tzschentke TM, Schmidt WJ (1996) Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist. Eur J Pharmacol 295:137-146
64. Tzschentke TM, Schmidt WJ (1999) Memantine does not substantially affect brain stimulation reward: comparison with MK-801. Brain Res 845:192-198
65. Wenk GL, Zajaczkowski W, Danysz W (1997) Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B. Behav Brain Res 83:129-133
66. Wise RA (1996a) Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319-340
67. Wise RA (1996b) Neurobiology of addiction. Curr Opin Neurobiol 6:243-251
68. Wise RA, Munn E (1993) Effects of repeated amphetamine injections on lateral hypothalamic brain stimulation reward and subsequent locomotion. Behav Brain Res 55:195-201
69. Yeomans JS, Mathur A, Tampakeras M (1993) Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons. Behav Neurosci 107:1077-1090
70. Zhang J, Chiodo LA, Freeman AS (1992) Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res 590:153-163